Certara 获得 FDA 的研究基金用于进一步推进生物模拟技术在仿制药虚拟生物等效性评估中的应用
23 sept. 2021 00h42 HE
|
Certara USA, Inc.
新泽西州普林斯顿, Sept. 23, 2021 (GLOBE NEWSWIRE) -- 作为生物模拟领域的全球领军者，Certara（纳斯达克股票代码：CERT）今天宣布获得美国食品药品监督管理局 (FDA) 的研究基金，以验证并扩展用于评估虚拟生物等效性 (VBE) 的生物模拟模型，进而有助于促进更安全、更快速且更具性价比的仿制药开发。 生物等效性 (BE)...
Certara Announces New Clinical Science Group and Adds Senior Scientific Experts
22 sept. 2021 08h00 HE
|
Certara
PRINCETON, N.J., Sept. 22, 2021 (GLOBE NEWSWIRE) -- Certara, a global leader in biosimulation, today announced that it is expanding its Integrated Drug Development (IDD) division with a new clinical...
Certara Awarded FDA Grant to Further Advance Virtual Bioequivalence Assessments of Generic Medicines Using Biosimulation
20 sept. 2021 08h00 HE
|
Certara
PRINCETON, N.J., Sept. 20, 2021 (GLOBE NEWSWIRE) -- Certara (Nasdaq: CERT), a global leader in biosimulation, today announced the Company has been awarded a grant from the U.S. Food and Drug...
Certara Announces Closing of its Public Offering of Common Stock and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
13 sept. 2021 16h30 HE
|
Certara
PRINCETON, N.J., Sept. 13, 2021 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that it closed its public offering of 23,000,000 shares of common...
Certara Announces Pricing of Public Offering of Common Stock
08 sept. 2021 21h01 HE
|
Certara
PRINCETON, N.J., Sept. 08, 2021 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced the pricing of its underwritten public offering of shares of its...
Certara Announces Proposed Public Offering of Common Stock
03 sept. 2021 06h10 HE
|
Certara
PRINCETON, N.J., Sept. 03, 2021 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced a proposed underwritten public offering of 20,000,000 shares of...
Certara to Participate in Upcoming Investor Conferences
31 août 2021 16h30 HE
|
Certara
PRINCETON, N.J., Aug. 31, 2021 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that Company management will participate in a fireside chat at the...
Certara Reports Second Quarter 2021 Financial Results
05 août 2021 16h20 HE
|
Certara
PRINCETON, N.J., Aug. 05, 2021 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today reported its financial results for the second quarter of fiscal year 2021. ...
Certara to Acquire Pinnacle 21, a Leader in Data Standardization Software for Pharmaceutical Clinical Data
05 août 2021 16h15 HE
|
Certara
PRINCETON, N.J., Aug. 05, 2021 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced it has signed a definitive agreement to acquire Pinnacle 21 for...
Mubadala Invests in Global Biosimulation Leader Certara
27 juil. 2021 17h03 HE
|
Certara
PRINCETON, N.J., July 27, 2021 (GLOBE NEWSWIRE) -- Certara (NASDAQ: CERT), a global leader in biosimulation, today announced that Mubadala Investment Company (Mubadala) has made an approximately...